Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RiouxVision is a medical technology company specializing in the development of advanced visualization systems for minimally invasive surgical procedures. The company's primary innovation is a high-definition, single-use endoscopic platform designed to provide clinicians with superior image quality while addressing the challenges of cross-contamination and the high costs associated with traditional reusable endoscopes. By offering a disposable solution, RiouxVision aims to streamline hospital workflows, reduce reprocessing requirements, and improve patient safety. The technology is particularly applicable to endoscopy and urology markets. In July 2022, RiouxVision was acquired by Boston Scientific, which integrated the technology into its endoscopy and surgical visualization portfolios.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rioux Vision.